NCT05088876View on ClinicalTrials.gov

Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Pain
Interventions
DRUG

Placebo

Blinded withdrawal of regular co-medication with paracetamol

DRUG

Paracetamol

Paracetamol in the dose already used

Trial Locations (2)

Unknown

RECRUITING

Kantonsspital Baden, Baden

RECRUITING

Inselspital, Bern University Hospital, Bern

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER